Skip to main content
Christopher Pleyer, MD, Hematology, Bethesda, MD

ChristopherPleyerMD

Hematology Bethesda, MD

Clotting Disorder

Physician

Dr. Pleyer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Pleyer's full profile

Already have an account?

  • Office

    10 Center Dr
    Bethesda, MD 20814
    Phone+1 216-444-2200

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Internal Medicine, 2013 - 2016
  • Other
    OtherClass of 2012

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2018 - 2026
  • DC State Medical License
    DC State Medical License 2018 - 2024
  • OH State Medical License
    OH State Medical License 2013 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Lectures

  • Response to the Shingrix Varicella Zoster Virus (VZV) Vaccine in Patients with Chronic Lymphocytic Leukemia (CLL) That Are Treatment Naive or Treated with a Bruton's T... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Partial Reconstitution of Humoral and Cellular Immunity in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Partial Reconstitution of Humoral and Cellular Immunity in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018